Cargando…

Perioperative Circulating Tumor DNA in Colorectal Liver Metastases: Concordance with Metastatic Tissue and Predictive Value for Tumor Burden and Prognosis

BACKGROUND: The surgical resection of colorectal cancer with liver metastases (CLM) has proven to be the most important modality for long-term survival, while effective biomarkers for outcome prediction or postoperative surveillance are still lacking. Currently, circulating biomarkers obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Yiping, Ma, Xiaoji, Chen, Ke, Liu, Fangqi, Cai, Sanjun, Han-Zhang, Han, Hou, Ting, Xiang, Jianxing, Peng, Junjie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061429/ https://www.ncbi.nlm.nih.gov/pubmed/32184665 http://dx.doi.org/10.2147/CMAR.S240869

Ejemplares similares

The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision
por: Chen, Yikuan, et al.
Publicado: (2022)

Locus‐specific concordance of genomic alterations between tissue and plasma circulating tumor DNA in metastatic melanoma
por: Calapre, Leslie, et al.
Publicado: (2018)

Concordance between whole exome sequencing of circulating tumor DNA and tumor tissue
por: Leenanitikul, Julanee, et al.
Publicado: (2023)

Concordance of Targeted Sequencing from Circulating Tumor DNA and Paired Tumor Tissue for Early Breast Cancer
por: Huang, Chi-Cheng, et al.
Publicado: (2023)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer
por: Dhaka, Sonia, et al.
Publicado: (2022)

Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response
por: Sun, Wen-Wen, et al.
Publicado: (2017)

Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma
por: Nakano, Kosuke, et al.
Publicado: (2022)

Patients with Concordant Triple-Negative Phenotype between Primary Breast Cancers and Corresponding Metastases Have Poor Prognosis
por: Shin, Hee-Chul, et al.
Publicado: (2016)

The molecular heterogeneity of sporadic colorectal cancer with different tumor sites in Chinese patients
por: Peng, Junjie, et al.
Publicado: (2017)

Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer
por: Xu, Bing, et al.
Publicado: (2020)

Concordance between TP53 alterations in blood and tissue: impact of time interval, biopsy site, cancer type and circulating tumor DNA burden
por: Bieg‐Bourne, Cheyennedra C., et al.
Publicado: (2020)

Quantitation of the Regional Lymph Node Metastatic Burden and Prognosis in Malignant Mammary Tumors of Dogs
por: de Araújo, M.R., et al.
Publicado: (2015)

Impact of Non-Pulmonary Visceral Metastases in the Prognosis and Practice of Metastatic Testicular Germ Cell Tumors
por: Rossi, Lorena, et al.
Publicado: (2016)

Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study
por: Li, Shih-Hong, et al.
Publicado: (2022)

The Characteristics and Prognostic Effect of E-Cadherin Expression in Colorectal Signet Ring Cell Carcinoma
por: Wang, Renjie, et al.
Publicado: (2016)

Association of Circulating Tumor DNA (ctDNA) Detection in Metastatic Renal Cell Carcinoma (mRCC) with Tumor Burden
por: Maia, Manuel Caitano, et al.
Publicado: (2017)

Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer
por: Liu, Minetta C., et al.
Publicado: (2022)

The Discordance of Gene Mutations between Circulating Tumor Cells and Primary/Metastatic Tumor
por: Wang, Qi, et al.
Publicado: (2019)

Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer
por: Podolak, Jennifer, et al.
Publicado: (2017)

ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis
por: Urso, Loredana, et al.
Publicado: (2021)

The Impact of Postoperative Tumor Burden on Patients With Brain Metastases
por: Aftahy, Amir Kaywan, et al.
Publicado: (2022)

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
por: Adalsteinsson, Viktor A., et al.
Publicado: (2017)

In Vivo Lymphatic Circulating Tumor Cells and Progression of Metastatic Disease
por: Han, Mikyung, et al.
Publicado: (2020)

Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis
por: Mi, Junjie, et al.
Publicado: (2023)

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
por: Wang, Ruiliang, et al.
Publicado: (2023)

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
por: Smith, Jarrod T., et al.
Publicado: (2020)

Low Concordance Between T-Cell Densities in Matched Primary Tumors and Liver Metastases in Microsatellite Stable Colorectal Cancer
por: Dagenborg, Vegar Johansen, et al.
Publicado: (2021)

Establishment and validation of a novel nomogram incorporating clinicopathological parameters into the TNM staging system to predict prognosis for stage II colorectal cancer
por: Mo, Shaobo, et al.
Publicado: (2020)

Recognition of Anterior Peritoneal Reflections and Their Relationship With Rectal Tumors Using Rectal Magnetic Resonance Imaging
por: Yiqun, Sun, et al.
Publicado: (2016)

Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
por: Aktas, Bahriye, et al.
Publicado: (2016)

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma – results of a prospective biomarker study
por: Forschner, Andrea, et al.
Publicado: (2019)

BAP1 and PBRM1 in metastatic clear cell renal cell carcinoma: tumor heterogeneity and concordance with paired primary tumor
por: Eckel-Passow, Jeanette E., et al.
Publicado: (2017)

Circulating tumor DNA for prognosis assessment and postoperative management after curative‐intent resection of colorectal liver metastases
por: Reinert, Thomas, et al.
Publicado: (2022)

Concordance of anaplastic lymphoma kinase (ALK) gene rearrangements between circulating tumor cells and tumor in non-small cell lung cancer
por: Tan, Chye Ling, et al.
Publicado: (2016)

Prospective Evaluation of the Concordance of Commercial Circulating Tumor DNA Alterations with Tumor-Based Sequencing across Multiple Soft Tissue Sarcoma Subtypes
por: Demoret, Bryce, et al.
Publicado: (2019)

Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
por: Boutin, Mélina, et al.
Publicado: (2023)

Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer
por: Elez, Elena, et al.
Publicado: (2019)

Nomograms for predicting specific distant metastatic sites and overall survival of colorectal cancer patients: A large population‐based real‐world study
por: Mo, Shaobo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jktuhpohpm5k0ve45u49ccf8a4